Current gene therapy research aims to target, for example, upstream targets of the GSH system or molecules associated with it (such as Nrf2, GPX, SLC7A11), genes aberrantly expressed in myocardial injury, and noncoding RNAs regulating mRNA transcription [76, 202, 250,251,252,253]
Potential improvement in body composition supporting physical function
Topical BPC-157 may be suitable for: For most therapeutic goals beyond surface-level skin concerns, injectable or oral forms will typically deliver stronger results
In the liver, it offers antioxidant support for liver tissue protection and promotes p450 phase II conjugation pathways to support detoxification